1
/
of
0
FDA CDER Exclusivity Board Memo – NDA 209988 (Furoscix)
FDA CDER Exclusivity Board Memo – NDA 209988 (Furoscix)
Regular price
$69.00 USD
Regular price
Sale price
$69.00 USD
Unit price
/
per
Original Request: A copy of any memorandum prepared by the CDER Exclusivity Board with respect to NDA 209988 [Furoscix (furosemide injection)] approved on October 7, 2022.
Couldn't load pickup availability
- Status: Pending Fast-Track Request
- Delivery: Approximately 1 to 2 weeks when the FOIA office is operating at regular capacity
NOTE: This document is not currently in our library. Upon purchase, we will request the document from the FDA FOIA office. Learn more about Fast-Track Requests here.
View full details